Edgestream Partners, L.P. Natera, Inc. Transaction History

Edgestream Partners, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$85.28 - $112.6 $1.86 Million - $2.45 Million	21,782 New	21,782 $2.36 Million
Q4 2023 Feb 14, 2024	BUY	$37.55 - $62.64 $141,601 - $236,215	3,771 New	3,771 $236,000
Q2 2023 Aug 10, 2023	BUY	$47.08 - $55.16 $118,971 - $139,389	2,527 Added 30.15%	10,909 $530,000
Q1 2023 May 15, 2023	BUY	$36.57 - $58.29 $306,529 - $488,586	8,382 New	8,382 $465,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Edgestream Partners, L.P. with notifications on news.